Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 186, doi. 10.1002/phar.2373
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2020 AND VI 40 AND IP 3
Results: 9
1
2
Establishing the Therapeutic Index of Fluid Resuscitation in the Septic Patient: A Narrative Review and Meta‐Analysis.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 256, doi. 10.1002/phar.2371
- By:
- Publication type:
- Article
3
Oseltamivir for All: Should It Become an Over‐the‐Counter Medication for Influenza Treatment?
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 182, doi. 10.1002/phar.2370
- By:
- Publication type:
- Article
4
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 204, doi. 10.1002/phar.2369
- By:
- Publication type:
- Article
5
The Impact of Proximal Roux‐en‐Y Gastric Bypass Surgery on Acetaminophen Absorption and Metabolism.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 191, doi. 10.1002/phar.2368
- By:
- Publication type:
- Article
6
Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 211, doi. 10.1002/phar.2367
- By:
- Publication type:
- Article
7
Evaluation of Eravacycline: A Novel Fluorocycline.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 221, doi. 10.1002/phar.2366
- By:
- Publication type:
- Article
8
Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung Cancer.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 239, doi. 10.1002/phar.2364
- By:
- Publication type:
- Article
9
Issue Information.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 3, p. 179, doi. 10.1002/phar.2249
- Publication type:
- Article